Stuart A. Arbuckle - 05 Jan 2026 Form 4 Insider Report for ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Role
Director
Signature
By: Brett Budzinski, Attorney-in-Fact For: Stuart A. Arbuckle
Issuer symbol
ALNY
Transactions as of
05 Jan 2026
Net transactions value
$0
Form type
4
Filing time
07 Jan 2026, 16:17:43 UTC
Previous filing
02 Jul 2025
Next filing
12 Jan 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Arbuckle Stuart A Director 675 WEST KENDALL STREET, HENRI A. TERMEER SQUARE, CAMBRIDGE By: Brett Budzinski, Attorney-in-Fact For: Stuart A. Arbuckle 07 Jan 2026 0001557290

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALNY Stock Option (right to buy) Award $0 +3,279 $0.000000 3,279 05 Jan 2026 Common Stock 3,279 $397.83 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option will vest as to one third of the shares on each of the first, second and third anniversaries of the date of grant.